Miró, M. ¿Se Acerca El Fin De La Succinilcolina? Estudio Dosis-Respuesta De Sugammadex: Reversal of Profound, High-Dose Rocuronium-Induced Neuromuscular Blockade by Sugammadex at Two Different Time Points: An International, Multicenter, Randomized, Dose-Finding, Safety Assessor-Blinded, Phase II Trial. Pühringer FK, Rex C, Sielenkämper AW, Claudius C, Larsen PB, Prins ME, Eikermann M, Khuenl-Brady KS. Anesthesiology 2008; 109 (2): 188-97. Rev Elect AnestesiaR 2009, 1, 1.